Results 161 to 170 of about 51,654 (292)

Acute ST-Elevation Myocardial Infarction after Coronary Stent Fracture

open access: yesJournal of Tehran University Heart Center, 2016
The invention of the drug-eluting stent (DES) has brought about revolutionary changes in the field of interventional cardiology. In the DES era, in-stent restenosis has declined but new issues such as stent thrombosis have emerged.
Abbasali Rafighdust, Ali Eshraghi
doaj  

Preclinical Therapeutic Efficacy of the Ciprofloxacin Azithromycin Sinus Stent for Pseudomonas aeruginosa Sinusitis

open access: yes
International Forum of Allergy &Rhinology, Volume 15, Issue 5, Page 561-564, May 2025.
Adam J. Skelton   +6 more
wiley   +1 more source

Thrombosis prevention in percutaneous coronary interventions

open access: yesКардиоваскулярная терапия и профилактика, 2009
The introduction of drug-eluting stents has been a major achievement of interventional cardiology. These stents  demonstrate good clinical effectiveness and safety profile.
V. P. Lupanov, A. N. Samko
doaj  

Percutaneous Coronary Intervention With a Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients Receiving Dialysis: A National Study From Taiwan

open access: yesKidney Medicine
Rationale & Objective: We aimed to study the comparative effectiveness of percutaneous coronary intervention with drug-eluting stent and coronary artery bypass grafting in patients receiving dialysis.
Szu-Yu Pan   +12 more
doaj  

High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo

open access: yesBioactive Materials, 2020
Pharmacokinetic analyses were performed using 20 pigs for 120-days implantation, while one sirolimus-eluting stent was implanted into one of their coronary artery.
Shanshan Chen   +8 more
doaj  

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer

open access: yesJournal of Cardiovascular and Thoracic Research, 2011
Introduction: Drug-eluting stents (DES) have significantly decreased the need for repeat coronary revascularization but concerns remain regarding the safety of first and second generation DES.
Ahmad Separham   +3 more
doaj   +1 more source

Drug-Eluting Balloon: An Overview of Clinical Evidences on Safety and Effectiveness

open access: yesJournal of Pharmacoeconomics and Pharmaceutical Management, 2015
Background: Recent advances in the intravascular diseases have led to the entrance of drug-eluting balloon (DEB) technology. The DEB is a relatively new and easier way to treat vascular stenosis.
Khosro Keshavarz   +4 more
doaj  

Clinical Significance of Optical Coherence Tomography–Guided Percutaneous Coronary Intervention for In‐Stent Restenosis Within Drug‐Eluting Stents: Impact on Patient Outcomes

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The evidence for optical coherence tomography (OCT)–guided percutaneous coronary intervention (PCI) in improving the prognosis of individuals with in‐stent restenosis (ISR) is lacking.
Yan Han   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy